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Cardiac tamponade is a medical emergency that requires immediate treatment. Caused by the 
development of fluid in the pericardial space, it can result in a severe decrease in cardiac output. 
When encountering patients with severe hypotension and tachycardia, emergency physicians 
must always consider the diagnosis of tamponade to facilitate prompt and effective treatment 
and stabilization. We report our experience with a patient who developed life-threatening cardiac 
tamponade within a span of less than 24 hours. [Clin Pract Cases Emerg Med. 2019;3(3):267-270.]
INTRODUCTION
Cardiac tamponade is a medical emergency that 
is caused by compression of the cardiac chambers due 
to an accumulation of fluid in the pericardial space.1,2 
Approximately 15-30 milliliters (mL) of fluid lies between 
the parietal pericardium and visceral pericardium in normal 
physiologic states.3,4 If fluid accumulation surpasses a 
critical threshold, cardiac output and blood pressure drop 
precipitously.4,5 However, due to the adaptive and elastic 
properties of the pericardium, the amount of pericardial fluid 
that can be tolerated is related to the rate of the accumulation 
of fluid.1 Chronic accumulation of fluid gives the pericardium 
time to gradually increase its compliance; thus, tamponade 
may not be seen until a large amount of fluid has developed in 
the pericardial sac. In acute settings, the pericardium does not 
have time to increase its compliance, leading to a rapid decline 
in cardiac output. 
Several causes of cardiac tamponade have been identified, 
including idiopathic, infectious, autoimmune, malignancy, 
trauma, and metabolic etiologies.6-8 One study identified the 
most common diagnoses of patients with pericardial effusions 
as follows: acute idiopathic pericarditis (20%), iatrogenic 
cause (16%), malignancy (13%), chronic idiopathic effusion 
(9%), acute myocardial infarction (8%), end stage renal 
disease (6%), and tuberculosis or bacterial infection (4%).4,9 
The clinical presentation of cardiac tamponade can 
vary widely. Acute presentations of tamponade can occur 
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within minutes or hours, as is typically seen in trauma, aortic 
rupture, or iatrogenic result from an invasive procedure. 
Acute presentations frequently result in life-threatening 
hypotension necessitating immediate interventions to 
decrease the pericardial pressure.10 In contrast, the subacute 
presentations can occur over days to weeks and hypotension is 
relatively uncommon.4,11 One study demonstrated that 27-43% 
of patients presenting with subacute cardiac tamponade are 
actually hypertensive, with systolic blood pressures ranging 
from 127 millimeter of mercury (mmHg) to 144 mmHg, 
likely secondary to increased activity of the sympathetic 
nervous system.11,12 Clinical findings of tamponade can vary, 
and no sensitive or specific signs have been identified.13 
Findings may include tachycardia, jugular venous distension, 
pulsus paradoxus, tachypnea, hypotension, hypertension, 
and pericardial rub. The classic presentation of Beck’s triad, 
characterized by hypotension, increased jugular venous 
pressure, and muffled heart sounds, is seen only in a small 
number of acute cardiac tamponade cases.14 
When considering cardiac tamponade in patients, the 
diagnostic workup should include an electrocardiogram, chest 
radiograph, and echocardiogram. While tamponade is mostly 
a clinical diagnosis, echocardiography is highly recommended 
by multiple task forces and societies.13,15 If available in the 
emergency department (ED), point-of-care ultrasound should 
be used by emergency physicians to help identify and possibly 
treat acute cardiac tamponade.
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What do we already know about this clinical 
entity? 
Cardiac tamponade is a life-threatening 
illness that requires emergent recognition and 
treatment.
What makes this presentation of disease 
reportable? 
We present a unique case of a patient 
who developed severe, life-threatening 
cardiac tamponade in under 24 hours that 
necessitated immediate intervention. 
What is the major learning point? 
Cardiac tamponade can develop rapidly, and 
recent negative imaging does not rule it out. 
Point-of-care ultrasound can help rapidly 
identify this disease process. 
How might this improve emergency 
medicine practice? 
Emergency physicians must always 
consider cardiac tamponade in hypotensive, 
tachycardic patients.
Our report describes a life-threatening presentation of 
cardiac tamponade that developed over the span of one day in 
a young, female patient. 
CASE REPORT
A 23-year-old African-American female presented 
to our ED with one day of sharp, midline chest pain that 
radiated to her jaw and left arm. She reported mild associated 
shortness of breath but no exertional symptoms. The review 
of systems was otherwise unremarkable. Her past medical 
history was significant for adrenal insufficiency on daily 
hydrocortisone, hypothyroidism, and two prior episodes of 
pericardial effusion with previous drainage procedures. Vital 
signs included a blood pressure of 129/96 mmHg, heart rate 
99 beats per minute, and oxygen saturation 100% on room 
air. The patient was afebrile. Initial laboratory workup was 
unremarkable with a negative troponin. Due to the patient’s 
history of pericardial effusions, a formal transthoracic 
echocardiogram was performed, which demonstrated normal 
systolic function with an ejection fraction of 50-55% and no 
evidence of a pericardial effusion (Video 1). The patient was 
then discharged home.
The following day, the patient presented to our ED 
with similar symptoms, including chest pain and shortness 
of breath. Upon evaluation, her vital signs demonstrated 
severe hypotension with a blood pressure of 71/52 mmHg, 
heart rate 121 beats per minute, respiratory rate 16 breaths 
per minute, oxygen saturation 100% on room air, and 
temperature 36.8°C.  Her exam was now significant for 
depressed mental status and lethargy. A point-of-care 
cardiac ultrasound was performed, which demonstrated 
a large amount of pericardial fluid and right ventricular 
collapse. Immediate transthoracic echocardiogram 
confirmed these findings (Videos 2 and 3).  
Interventional cardiology and cardiovascular surgery 
were consulted, and a decision was made to take the patient 
to the operating room emergent pericardiectomy. In the 
operating room, approximately 300 mL of turbid, yellow 
fluid was evacuated from the underlying pericardium. A 24 
French Blake drain was placed in the pericardium and the 
patient was admitted to the intensive care unit.  
With the patient’s previous pericardial effusion, past 
laboratory workup demonstrated high titers for coxsackie 
B virus. Upon this admission, a viral panel was negative, 
including hepatitis B panel, influenza, respiratory syncytial 
virus, corona virus, metapneumovirus, parainfluenza virus 
types 1,3, and 4, Epstein-Barr virus, cytomegalovirus, 
human immunodeficiency virus, coxsackie, influenza A, 
myocoplasma pneumonia, Chlamydia pneumoniae, buccal 
virus, and rhinovirus. Rheumatologic workup was also 
negative, including antinuclear antibody, anti-double stranded 
deoxyribonucleic acid, antimicrosomal antibody, anticentromere 
antibody, Sjogren’s syndrome A and B, Smith antibody, celiac 
screen, anti-Jo 1 antibody, and anti-SCL–70 antibody (anti-
topoisomerase I). Further testing for anti-21 alpha hydroxylase 
and anti-TPO antibodies were also negative. 
Pericardial fluid analysis demonstrated predominantly 
acute inflammatory cells without any evidence of malignancy. 
Pericardial biopsy results were unrevealing. Repeat 
echocardiogram demonstrated normal left ventricular ejection 
fraction of 50-55% and no significant pericardial effusion. The 
patient was discharged 10 days following initial presentation 
and has not had any subsequent episodes of cardiac tamponade 
or pericardial effusions diagnosed at our institution. 
DISCUSSION
Our report highlights a unique presentation of life-
threatening, atraumatic cardiac tamponade that developed 
over the span of 24 hours in a young female with a history 
of pericardial effusion. 
Echocardiography has a class I recommendation 
to evaluate most pericardial diseases as it can identify 
anatomic, physiologic, and hemodynamic abnormalities of 
the heart.15 When evaluating for pericardial effusions, this 
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Video 2. A formal parasternal long-axis view of the heart of the 
patient when she re-presented the following day. A large pericardial 
effusion can be seen. (Arrows indicate surrounding fluid).
Video 3. A formal apical four-chamber view of the heart demon-
strating a large pericardial effusion (Top arrow demonstrates fluid, 
bottom arrow demonstrates right atrial collapse).
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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imaging modality can estimate the size and location of the 
effusion. Effusions can be classified based on quantitative 
measurements: small <10 mm, moderate 10-20 mm, and large 
>20 mm in size.13 Echocardiographic signs of tamponade 
include collapsing cardiac chambers, changes in chamber 
volumes and flows with respiration, and inferior venous 
cava dilation.13 While any heart chambers may collapse in 
tamponade, the most common findings are right-sided atrial 
and ventricular collapse, and studies have demonstrated 
that right atrial collapse is highly sensitive and specific for 
tamponade if it persists for longer than one-third of the cardiac 
cycle.15 Collapse of the right ventricle is less sensitive than 
right atrial collapse, but very specific for tamponade.16 
This patient was treated by a cardiothoracic surgeon 
who performed a pericardial window to remove the 
pericardial fluid. Most patients with cardiac tamponade 
require drainage of the effusion to improve symptoms. The 
two methods of removal include percutaneous drainage 
by a pericardiocentesis and surgical drainage by creating 
a pericardial window (pericardiectomy). While each 
method has its advantages, our patient underwent surgical 
pericardiectomy. This procedure allows the clinician to 
obtain pericardial biopsies for further evaluation, which was 
an important consideration in this patient given her history 
of recurrent effusions. For our patient, analysis of the fluid 
and subsequent rheumatologic and malignant workups were 
negative. Interestingly, the patient tested negative for the 
most common etiologies of tamponade. Upon discharge, 
a repeat echocardiogram demonstrated no evidence of re-
accumulation of a pericardial effusion. 
CONCLUSION
Despite the acute, life-threatening presentation of cardiac 
tamponade, this patient was successfully treated by surgical 
pericardiectomy to remove pericardial fluid. While there 
are many known causes of cardiac tamponade, our patient 
had a completely negative workup. This case illustrates the 
importance for emergency physicians to always consider the 
diagnosis of cardiac tamponade when encountering patients 
with severe hypotension and tachycardia. Without prompt 
and proper identification of this diagnosis, patients have a 
high likelihood of experiencing severe morbidity and possibly 
mortality. Immediate point-of-care cardiac ultrasound and 
transthoracic echocardiography can aid in the diagnosis. In 
conclusion, we report a unique presentation of severe cardiac 
tamponade that developed within a 24-hour interval period 
and was successfully treated with a pericardial window.
Video 1. A formal parasternal long-axis view of the heart in the 
patient when she initially presented to the emergency department. 
No significant pericardial effusion is seen.
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